Methyl Alcohol

Methyl Alcohol

SCHEMBL7565244

CO.O=C(CCCC(=O)OC1c2ccccc2-c2ccccc21)OCc1cccc2c1Cc1ccccc1-2

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.41
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 4/20 0.34
GAA P10253 1/20 0.34
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33
EPHX2 P34913 3/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
HTR2C P28335 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
POLB P06746 1/20 0.32
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
GABRP O00591 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5497718 0.87 PNMT (0.53) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL5497721 0.83 PNMT (0.48) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL7565254 0.81 KMT2A (0.40) PNMTNPC1RAB9AALDH1A1HTR7
SCHEMBL5499370 0.79 PNMT (0.42) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL4839271 0.79 PNMT (0.51) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL4059189 0.78 PNMT (0.54) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL27429983 0.78 PNMT (0.52) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL6849876 0.78 PNMT (0.50) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL19384366 0.77 RAB9A (0.50) PNMTNPC1RAB9AALDH1A1GAA
SCHEMBL8474155 0.76 PNMT (0.51) PNMTNPC1RAB9AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1225918-A2 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER Merck & Co., Inc. (US) 2002-07-31 EP disclosed
WO-2001028593-A2 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO., INC. (US) 2001-04-26 WO disclosed